Collectively, our findings demonstrate that smumf cells at P10, which secrete HGF, can effectively manage tendinopathy by inhibiting the NF-κB and MAPK signaling pathways in tenocytes, thereby reducing inflammation and highlighting their potential as a cell therapy. Here, HGF is linked to disease of the tendon.